MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$31,660K
Net Income
-$49,779K
Net Profit Margin
-157.23%
EPS
-$0.79
Unit: Thousand (K) dollars
Revenue Breakdown
Collaboration Revenue Related Pa...
Other Revenue
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
2024-09-30
Total revenues
31,660
11,871
Selling, general and administrative
61,997
53,219
Restructuring
-230
-
Research and development
23,917
54,576
Cost of revenues
-55
5,278
Total operating costs and expenses
85,629
113,073
Loss from operations
-53,969
-101,202
Other income (expense), net
-6
9
Interest income
4,323
7,642
Net loss
-49,652
-93,551
Unrealized gain (loss) on marketable securities
-127
1,592
Total comprehensive loss
-49,779
-91,959
Basic EPS
-0.79
-1.53
Diluted EPS
-0.79
-1.53
Basic Average Shares
62,610,598
61,116,524
Diluted Average Shares
62,610,598
61,116,524
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$49,779K
Net loss
-$49,652K
Unrealized gain (loss) on
marketable securities
-$127K
Interest income
$4,323K
Collaboration Revenue Related
Party
$23,209K
Other Revenue
$8,451K
Loss from operations
-$53,969K
Total revenues
$31,660K
Other income
(expense), net
-$6K
Total operating costs
and expenses
$85,629K
Restructuring
-$230K
Cost of revenues
-$55K
Selling, general and
administrative
$61,997K
Research and development
$23,917K
Buy us a coffee
Sage Therapeutics, Inc. (SAGE)
Sage Therapeutics, Inc. (SAGE)